You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

proteasome inhibitor,

Showing 1 - 25 of 7,614
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Kidney Transplantation, End Stage Kidney Disease (ESRD) Trial in Chicago (Belatacept Injection)

Recruiting
  • Kidney Transplantation
  • End Stage Kidney Disease (ESRD)
  • Belatacept Injection
  • Chicago, Illinois
    University of Chicago
May 13, 2022

AML, AML, Adult Trial in Indianapolis (TAK-659, Ixazomib)

Terminated
  • AML
  • AML, Adult
  • Indianapolis, Indiana
    Indiana University Melvin and Bren Simon Cancer Center
Mar 15, 2022

Multiple Myeloma Trial (Elranatamab (PF-06863135))

Temporarily not available
  • Multiple Myeloma
  • Elranatamab (PF-06863135)
  • (no location specified)
Jul 15, 2022

Based on Maintenance Therapy Post Autologous Stem Cell

Recruiting
  • Multiple Myeloma
  • Autologous Stem Cell Transplant
  • +2 more
  • Tampa, Florida
    Moffitt Cancer Center
Jul 27, 2022

Multiple Myeloma Trial in West Hollywood, Cary (Selinexor, Placebo (for selinexor), carfilzomib)

Withdrawn
  • Multiple Myeloma
  • West Hollywood, California
  • +1 more
Jan 24, 2023

Relapsed and/or Refractory Multiple Myeloma Trial in Japan (Ixazomib, Bortezomib, Carfilzomib)

Completed
Has Results
  • Relapsed and/or Refractory Multiple Myeloma
  • Kamogawa, Chiba, Japan
  • +22 more
Jul 27, 2022

MMRR Treated With Belantamab Mafotidine on Monotherapy

Not yet recruiting
  • Multiple Myeloma
  • Belantamab mafodotin
  • (no location specified)
May 23, 2022

Multiple Myeloma, Renal Impairment, Tumors, Plasma Cell Trial in Greece (Isatuximab, Pomalidomide, Dexamethasone)

Not yet recruiting
  • Multiple Myeloma
  • +7 more
  • Athens, Greece
  • +5 more
Mar 17, 2022

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Atlanta, Ann Arbor, Saint Louis (Dexamethasone, Ixazomib,

Active, not recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Atlanta, Georgia
  • +3 more
Jan 6, 2023

Multiple Myeloma Trial in Beijing, Jiang Su Province (Belantamab mafodotin)

Completed
  • Multiple Myeloma
  • Belantamab mafodotin
  • Beijing, China
  • +2 more
Feb 8, 2022

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Rochester (Carfilzomib, Dexamethasone, Pomalidomide)

Recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jun 3, 2022

Refractory Plasma Cell Myeloma, Recurrent Plasma Cell Myeloma Trial in United States (ixazomib citrate, dexamethasone,

Active, not recruiting
Has Results
  • Refractory Plasma Cell Myeloma
  • Recurrent Plasma Cell Myeloma
  • ixazomib citrate
  • +2 more
  • Scottsdale, Arizona
  • +4 more
Mar 28, 2022

Multiple Myeloma in Relapse Trial in Finland, Sweden (Carfilzomib for Inj 60 milligram (MG), Elotuzumab 400 MG, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma in Relapse
  • Carfilzomib for Inj 60 milligram (MG)
  • +2 more
  • Helsinki, Finland
  • +7 more
Mar 14, 2022

Plasma Cell Myeloma, Residual Disease Trial in Chicago (Ixazomib Citrate, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Plasma Cell Myeloma
  • Residual Disease
  • Ixazomib Citrate
  • +2 more
  • Chicago, Illinois
    University of Chicago
Oct 5, 2021

Acute Leukemia, Chronic Leukemia, Myelodysplastic Syndrome Trial in Atlanta (MLN9708)

Completed
Has Results
  • Acute Leukemia
  • +4 more
  • Atlanta, Georgia
    Northside Hospital
Sep 1, 2021

Relapse/Refractory Multiple Myeloma Trial in China (ATG-010)

Completed
  • Relapse/Refractory Multiple Myeloma
  • Beijing, Beijing, China
  • +16 more
Jul 27, 2022

Multiple Myeloma Trial (Belantamab mafodotin (GSK2857916) anti-BCMA-immunoconjugate)

Approved for marketing
  • Multiple Myeloma
  • Belantamab mafodotin (GSK2857916) anti-BCMA-immunoconjugate
  • (no location specified)
Mar 9, 2021

Elranatamab, Myeloma, Multiple Myeloma Trial in China (Elranatamab)

Recruiting
  • Elranatamab
  • +10 more
  • Fuzhou, Fujian, China
  • +18 more
Jan 18, 2023

Liposarcoma, Malignant Peripheral Nerve Sheath Tumors, Alveolar Soft Part Sarcoma Trial in New York (Selinexor, Ixazomib)

Withdrawn
  • Liposarcoma
  • +4 more
  • New York, New York
    Columbia University Medical Center
Nov 24, 2020

Multiple Myeloma Trial in Worldwide (Selinexor, Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Birmingham, Alabama
  • +60 more
Jan 24, 2023

Advanced Cancers Trial in Guangzhou, Changsha (TQB3602 Capsule + AK105 Injection)

Not yet recruiting
  • Advanced Cancers
  • TQB3602 Capsule + AK105 Injection
  • Guangzhou, Guangdong, China
  • +1 more
Apr 12, 2022

Quality of Life in Relapsed and/or Refractory Multiple Myeloma

Active, not recruiting
  • Multiple Myeloma
    • Morrisville, North Carolina
      Local Institution
    May 12, 2022

    Waldenstrom Macroglobulinemia, Waldenstrom's Macroglobulinemia Recurrent, Waldenstrom's Macroglobulinemia Refractory Trial

    Not yet recruiting
    • Waldenstrom Macroglobulinemia
    • +2 more
    • (no location specified)
    Jul 18, 2023

    Multiple Myeloma Trial in Canton (Lenalidomide)

    Recruiting
    • Multiple Myeloma
    • Canton, Ohio
      Gabrail Cancer & Research Center
    Oct 11, 2023

    Solid Tumor Trial in Madison (bortezomib, doxorubicin HCl)

    Completed
    • Unspecified Adult Solid Tumor, Protocol Specific
    • Madison, Wisconsin
      University of Wisconsin Comprehensive Cancer Center
    Dec 12, 2019